Global Rofecoxib Market Research Report 2020

Global Rofecoxib Market Research Report 2020

Table of Contents
1 Rofecoxib Market Overview
1.1 Product Overview and Scope of Rofecoxib
1.2 Rofecoxib Segment by Type
1.2.1 Global Rofecoxib Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Oral Suspension.
1.2.3 Tablet-Form
1.3 Rofecoxib Segment by Application
1.3.1 Rofecoxib Sales Comparison by Application: 2020 VS 2026
1.3.2 Osteoarthritis
1.3.3 Rheumatoid Arthritis
1.3.4 Juvenile Rheumatoid Arthritis
1.3.5 Acute Pain Conditions
1.3.6 Migraine
1.3.7 Dysmenorrhea
1.4 Global Rofecoxib Market Size Estimates and Forecasts
1.4.1 Global Rofecoxib Revenue 2015-2026
1.4.2 Global Rofecoxib Sales 2015-2026
1.4.3 Rofecoxib Market Size by Region: 2020 Versus 2026
1.5 Rofecoxib Industry
1.6 Rofecoxib Market Trends
2 Global Rofecoxib Market Competition by Manufacturers
2.1 Global Rofecoxib Sales Market Share by Manufacturers (2015-2020)
2.2 Global Rofecoxib Revenue Share by Manufacturers (2015-2020)
2.3 Global Rofecoxib Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Rofecoxib Manufacturing Sites, Area Served, Product Type
2.5 Rofecoxib Market Competitive Situation and Trends
2.5.1 Rofecoxib Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Rofecoxib Players (Opinion Leaders)
3 Rofecoxib Retrospective Market Scenario by Region
3.1 Global Rofecoxib Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Rofecoxib Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Rofecoxib Market Facts & Figures by Country
3.3.1 North America Rofecoxib Sales by Country
3.3.2 North America Rofecoxib Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Rofecoxib Market Facts & Figures by Country
3.4.1 Europe Rofecoxib Sales by Country
3.4.2 Europe Rofecoxib Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Rofecoxib Market Facts & Figures by Region
3.5.1 Asia Pacific Rofecoxib Sales by Region
3.5.2 Asia Pacific Rofecoxib Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Rofecoxib Market Facts & Figures by Country
3.6.1 Latin America Rofecoxib Sales by Country
3.6.2 Latin America Rofecoxib Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Rofecoxib Market Facts & Figures by Country
3.7.1 Middle East and Africa Rofecoxib Sales by Country
3.7.2 Middle East and Africa Rofecoxib Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Rofecoxib Historic Market Analysis by Type
4.1 Global Rofecoxib Sales Market Share by Type (2015-2020)
4.2 Global Rofecoxib Revenue Market Share by Type (2015-2020)
4.3 Global Rofecoxib Price Market Share by Type (2015-2020)
4.4 Global Rofecoxib Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Rofecoxib Historic Market Analysis by Application
5.1 Global Rofecoxib Sales Market Share by Application (2015-2020)
5.2 Global Rofecoxib Revenue Market Share by Application (2015-2020)
5.3 Global Rofecoxib Price by Application (2015-2020)
6 Company Profiles and Key Figures in Rofecoxib Business
6.1 Merck
6.1.1 Corporation Information
6.1.2 Merck Description, Business Overview and Total Revenue
6.1.3 Merck Rofecoxib Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Merck Products Offered
6.1.5 Merck Recent Development
6.2 Chengdu Meinkai Chemical Co. LTD
6.2.1 Chengdu Meinkai Chemical Co. LTD Corporation Information
6.2.2 Chengdu Meinkai Chemical Co. LTD Description, Business Overview and Total Revenue
6.2.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Chengdu Meinkai Chemical Co. LTD Products Offered
6.2.5 Chengdu Meinkai Chemical Co. LTD Recent Development
6.3 Wuhan Xinxin Jiali Biotechnology Co. LTD
6.3.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Corporation Information
6.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Description, Business Overview and Total Revenue
6.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Products Offered
6.3.5 Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Development
6.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
6.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Corporation Information
6.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Description, Business Overview and Total Revenue
6.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Products Offered
6.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Development
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description, Business Overview and Total Revenue
6.5.3 Pfizer Rofecoxib Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Pfizer Products Offered
6.5.5 Pfizer Recent Development
6.6 Tremeau
6.6.1 Tremeau Corporation Information
6.6.2 Tremeau Description, Business Overview and Total Revenue
6.6.3 Tremeau Rofecoxib Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Tremeau Products Offered
6.6.5 Tremeau Recent Development
7 Rofecoxib Manufacturing Cost Analysis
7.1 Rofecoxib Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Rofecoxib
7.4 Rofecoxib Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Rofecoxib Distributors List
8.3 Rofecoxib Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Rofecoxib Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Rofecoxib by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Rofecoxib by Type (2021-2026)
10.2 Rofecoxib Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Rofecoxib by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Rofecoxib by Application (2021-2026)
10.3 Rofecoxib Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Rofecoxib by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Rofecoxib by Region (2021-2026)
10.4 North America Rofecoxib Estimates and Projections (2021-2026)
10.5 Europe Rofecoxib Estimates and Projections (2021-2026)
10.6 Asia Pacific Rofecoxib Estimates and Projections (2021-2026)
10.7 Latin America Rofecoxib Estimates and Projections (2021-2026)
10.8 Middle East and Africa Rofecoxib Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Rofecoxib Sales (MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Rofecoxib Sales (MT) Comparison by Application: 2020 VS 2026
Table 3. Global Rofecoxib Market Size by Type (MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Rofecoxib Manufacturers Covered in This Study
Table 5. Global Rofecoxib Sales (MT) by Manufacturers (2015-2020)
Table 6. Global Rofecoxib Sales Share by Manufacturers (2015-2020)
Table 7. Global Rofecoxib Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Rofecoxib Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Rofecoxib Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Rofecoxib Sales Sites and Area Served
Table 11. Manufacturers Rofecoxib Product Types
Table 12. Global Rofecoxib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Rofecoxib by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rofecoxib as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Rofecoxib Players
Table 16. Global Rofecoxib Sales (MT) by Region (2015-2020)
Table 17. Global Rofecoxib Sales Market Share by Region (2015-2020)
Table 18. Global Rofecoxib Revenue (Million US$) by Region (2015-2020)
Table 19. Global Rofecoxib Revenue Market Share by Region (2015-2020)
Table 20. North America Rofecoxib Sales by Country (2015-2020) (MT)
Table 21. North America Rofecoxib Sales Market Share by Country (2015-2020)
Table 22. North America Rofecoxib Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Rofecoxib Revenue Market Share by Country (2015-2020)
Table 24. Europe Rofecoxib Sales by Country (2015-2020) (MT)
Table 25. Europe Rofecoxib Sales Market Share by Country (2015-2020)
Table 26. Europe Rofecoxib Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Rofecoxib Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Rofecoxib Sales by Region (2015-2020) (MT)
Table 29. Asia Pacific Rofecoxib Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Rofecoxib Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Rofecoxib Revenue Market Share by Region (2015-2020)
Table 32. Latin America Rofecoxib Sales by Country (2015-2020) (MT)
Table 33. Latin America Rofecoxib Sales Market Share by Country (2015-2020)
Table 34. Latin America Rofecoxib Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Rofecoxib Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Rofecoxib Sales by Country (2015-2020) (MT)
Table 37. Middle East and Africa Rofecoxib Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Rofecoxib Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Rofecoxib Revenue Market Share by Country (2015-2020)
Table 40. Global Rofecoxib Sales (MT) by Type (2015-2020)
Table 41. Global Rofecoxib Sales Share by Type (2015-2020)
Table 42. Global Rofecoxib Revenue (Million US$) by Type (2015-2020)
Table 43. Global Rofecoxib Revenue Share by Type (2015-2020)
Table 44. Global Rofecoxib Price (USD/MT) by Type (2015-2020)
Table 45. Global Rofecoxib Sales (MT) by Application (2015-2020)
Table 46. Global Rofecoxib Sales Market Share by Application (2015-2020)
Table 47. Global Rofecoxib Sales Growth Rate by Application (2015-2020)
Table 48. Merck Rofecoxib Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck Rofecoxib Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. Merck Main Product
Table 52. Merck Recent Development
Table 53. Chengdu Meinkai Chemical Co. LTD Rofecoxib Corporation Information
Table 54. Chengdu Meinkai Chemical Co. LTD Corporation Information
Table 55. Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. Chengdu Meinkai Chemical Co. LTD Main Product
Table 57. Chengdu Meinkai Chemical Co. LTD Recent Development
Table 58. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Corporation Information
Table 59. Wuhan Xinxin Jiali Biotechnology Co. LTD Corporation Information
Table 60. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Wuhan Xinxin Jiali Biotechnology Co. LTD Main Product
Table 62. Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Development
Table 63. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Corporation Information
Table 64. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Corporation Information
Table 65. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Main Product
Table 67. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Development
Table 68. Pfizer Rofecoxib Corporation Information
Table 69. Pfizer Corporation Information
Table 70. Pfizer Rofecoxib Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. Pfizer Main Product
Table 72. Pfizer Recent Development
Table 73. Tremeau Rofecoxib Corporation Information
Table 74. Tremeau Corporation Information
Table 75. Tremeau Rofecoxib Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Tremeau Main Product
Table 77. Tremeau Recent Development
Table 78. Sales Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Rofecoxib Distributors List
Table 81. Rofecoxib Customers List
Table 82. Market Key Trends
Table 83. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 84. Key Challenges
Table 85. Global Rofecoxib Sales (MT) Forecast by Type (2021-2026)
Table 86. Global Rofecoxib Sales Market Share Forecast by Type (2021-2026)
Table 87. Global Rofecoxib Revenue (Million US$) Forecast by Type (2021-2026)
Table 88. Global Rofecoxib Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 89. Global Rofecoxib Sales (MT) Forecast by Application (2021-2026)
Table 90. Global Rofecoxib Revenue (Million US$) Forecast by Application (2021-2026)
Table 91. Global Rofecoxib Sales (MT) Forecast by Region (2021-2026)
Table 92. Global Rofecoxib Sales Market Share Forecast by Region (2021-2026)
Table 93. Global Rofecoxib Revenue Forecast by Region (2021-2026) (US$ Million)
Table 94. Global Rofecoxib Revenue Market Share Forecast by Region (2021-2026)
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Rofecoxib
Figure 2. Global Rofecoxib Sales Market Share by Type: 2020 VS 2026
Figure 3. Oral Suspension. Product Picture
Figure 4. Tablet-Form Product Picture
Figure 5. Global Rofecoxib Consumption Market Share by Application: 2020 VS 2026
Figure 6. Osteoarthritis
Figure 7. Rheumatoid Arthritis
Figure 8. Juvenile Rheumatoid Arthritis
Figure 9. Acute Pain Conditions
Figure 10. Migraine
Figure 11. Dysmenorrhea
Figure 12. Global Rofecoxib Market Size 2015-2026 (US$ Million)
Figure 13. Global Rofecoxib Sales Capacity (MT) (2015-2026)
Figure 14. Global Rofecoxib Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Rofecoxib Sales Share by Manufacturers in 2020
Figure 16. Global Rofecoxib Revenue Share by Manufacturers in 2019
Figure 17. The Global 5 and 10 Largest Players: Market Share by Rofecoxib Revenue in 2019
Figure 18. Rofecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Rofecoxib Sales Market Share by Region (2015-2020)
Figure 20. Global Rofecoxib Sales Market Share by Region in 2019
Figure 21. Global Rofecoxib Revenue Market Share by Region (2015-2020)
Figure 22. Global Rofecoxib Revenue Market Share by Region in 2019
Figure 23. North America Rofecoxib Sales Market Share by Country in 2019
Figure 24. North America Rofecoxib Revenue Market Share by Country in 2019
Figure 25. U.S. Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 26. U.S. Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Canada Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 28. Canada Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Europe Rofecoxib Sales Market Share by Country in 2019
Figure 30. Europe Rofecoxib Revenue Market Share by Country in 2019
Figure 31. Germany Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 32. Germany Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. France Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 34. France Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. U.K. Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 36. U.K. Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Italy Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 38. Italy Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Russia Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 40. Russia Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Asia Pacific Rofecoxib Sales Market Share by Region in 2019
Figure 42. Asia Pacific Rofecoxib Revenue Market Share by Region in 2019
Figure 43. China Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 44. China Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Japan Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 46. Japan Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. South Korea Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 48. South Korea Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. India Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 50. India Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Australia Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 52. Australia Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Taiwan Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 54. Taiwan Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Indonesia Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 56. Indonesia Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Thailand Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 58. Thailand Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Malaysia Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 60. Malaysia Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Philippines Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 62. Philippines Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Vietnam Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 64. Vietnam Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Latin America Rofecoxib Sales Market Share by Country in 2019
Figure 66. Latin America Rofecoxib Revenue Market Share by Country in 2019
Figure 67. Mexico Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 68. Mexico Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Brazil Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 70. Brazil Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Argentina Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 72. Argentina Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Middle East and Africa Rofecoxib Sales Market Share by Country in 2019
Figure 74. Middle East and Africa Rofecoxib Revenue Market Share by Country in 2019
Figure 75. Turkey Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 76. Turkey Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Saudi Arabia Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 78. Saudi Arabia Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. U.A.E Rofecoxib Sales Growth Rate (2015-2020) (MT)
Figure 80. U.A.E Rofecoxib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Sales Market Share of Rofecoxib by Type (2015-2020)
Figure 82. Sales Market Share of Rofecoxib by Type in 2019
Figure 83. Revenue Share of Rofecoxib by Type (2015-2020)
Figure 84. Revenue Market Share of Rofecoxib by Type in 2019
Figure 85. Global Rofecoxib Sales Growth by Type (2015-2020) (MT)
Figure 86. Global Rofecoxib Sales Market Share by Application (2015-2020)
Figure 87. Global Rofecoxib Sales Market Share by Application in 2019
Figure 88. Global Revenue Share of Rofecoxib by Application (2015-2020)
Figure 89. Global Revenue Share of Rofecoxib by Application in 2020
Figure 90. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Chengdu Meinkai Chemical Co. LTD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Wuhan Xinxin Jiali Biotechnology Co. LTD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Tremeau Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Price Trend of Key Raw Materials
Figure 97. Manufacturing Cost Structure of Rofecoxib
Figure 98. Manufacturing Process Analysis of Rofecoxib
Figure 99. Rofecoxib Industrial Chain Analysis
Figure 100. Channels of Distribution
Figure 101. Distributors Profiles
Figure 102. Porter's Five Forces Analysis
Figure 103. North America Rofecoxib Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 104. North America Rofecoxib Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 105. Europe Rofecoxib Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 106. Europe Rofecoxib Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Latin America Rofecoxib Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 108. Latin America Rofecoxib Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Middle East and Africa Rofecoxib Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 110. Middle East and Africa Rofecoxib Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Asia Pacific Rofecoxib Sales (MT) and Growth Rate Forecast (2021-2026)
Figure 112. Asia Pacific Rofecoxib Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs